Related Experiment Video
Updated: Aug 13, 2025

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Pan-Cancer Analysis of the Roles and Driving Forces of RAB42
Mingzhu Zheng1, Wenhao Wang1, Yulan Bu2
1Department of Oncology, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang 261031, China.
Abstract:
RAB42 is a member of the RAS family. However, the roles and driving forces for RAB42 in tumors remain elusive. In this study, we performed a comprehensive pan-cancer analysis of the roles and regulatory mechanisms of RAB42 using bioinformatics and experiments. Online databases such as Sanger Box, ACLBI and TIDE were used to search for the expression levels, prognostic value and immune features of RAB42. We observed that RAB42 expression was upregulated in most tumors and was closely associated with poor prognosis. Enrichment analysis indicated that RAB42 was related to multiple biological functions, especially the immune process. RAB42 expression had a positive correlation with immune cell infiltration and immune checkpoint gene expression. RAB42 had a high predictive value for immunotherapy efficiency. Our study screened out susceptible drugs for the RAB42 protein by sensitivity analysis and virtual screening. Many key driver genes such as TP53 contributed to RAB42 expression. DNA methylation, super-enhancer and non-coding RNAs were the epigenetic factors responsible for RAB42 expression. In brief, RAB42 could serve as a diagnostic and prognostic biomarker in many tumor types. RAB42 might be a predictive biomarker and a new target for immunotherapy. Genetic and epigenetic factors were essential for RAB42 overexpression in tumors.
Insights
RAB42, a RAS family member, is upregulated in most cancers, correlating with poor prognosis and increased immune cell infiltration. This study identifies RAB42 as a potential diagnostic, prognostic, and immunotherapy biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- The roles and regulatory mechanisms of RAB42, a RAS family member, in tumor development are largely unknown.
- Understanding RAB42's function is crucial for identifying new cancer biomarkers and therapeutic targets.
Purpose of the Study:
- To conduct a comprehensive pan-cancer analysis of RAB42's roles and regulatory mechanisms.
- To investigate RAB42's potential as a diagnostic, prognostic, and predictive biomarker for cancer immunotherapy.
Main Methods:
- Utilized bioinformatics tools (Sanger Box, ACLBI, TIDE) for pan-cancer analysis of RAB42 expression, prognosis, and immune features.
- Performed enrichment analysis to identify associated biological functions and pathways.
- Conducted drug sensitivity analysis and virtual screening to identify potential therapeutic agents targeting RAB42.
Main Results:
- RAB42 expression is upregulated in the majority of tumors and associated with poor prognosis.
- RAB42 expression positively correlates with immune cell infiltration and immune checkpoint gene expression, indicating a role in the tumor immune microenvironment.
- RAB42 demonstrates high predictive value for immunotherapy efficacy and is linked to epigenetic factors like DNA methylation and non-coding RNAs.
Conclusions:
- RAB42 serves as a valuable diagnostic and prognostic biomarker across various tumor types.
- RAB42 represents a promising therapeutic target for cancer immunotherapy, with potential drug sensitivities identified.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
Related Concept Videos
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...